Driehaus Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Driehaus Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,735	Closed	-$259K	–	398
2023 Q1	$259K	Buy	3,735 +873	+31%	+$61.6K	﹤0.01%	354
2022 Q4	$206K	Buy	+2,862	New	+$216K	﹤0.01%	341
2020 Q3	–	Sell	-5,064	Closed	-$298K	–	395
2020 Q2	$298K	Buy	5,064 +81	+2%	+$4.84K	0.01%	340
2020 Q1	$278K	Buy	4,983 +1,225	+33%	+$74.9K	0.01%	352
2019 Q4	$241K	Buy	+3,758	New	+$215K	0.01%	469
2016 Q3	–	Sell	-8,198	Closed	-$603K	–	515
2016 Q2	$603K	Sell	8,198 -1,702	-17%	-$120K	0.02%	408
2016 Q1	$632K	Sell	9,900 -169	-2%	-$10.7K	0.02%	432
2015 Q4	$693K	Buy	+10,069	New	+$665K	0.02%	414
2014 Q4	–	Sell	-53,227	Closed	-$2.72M	–	500
2014 Q3	$2.72M	Sell	53,227 -4,466	-8%	-$223K	0.1%	259
2014 Q2	$2.8M	Sell	57,693 -92,894	-62%	-$4.58M	0.09%	287
2014 Q1	$7.82M	Buy	150,587 +38,685	+35%	+$2.06M	0.25%	111
2013 Q4	$5.95M	Buy	111,902 +100,323	+866%	+$5.11M	0.21%	146
2013 Q3	$536K	Sell	11,579 -1,363	-11%	-$59.8K	0.02%	388
2013 Q2	$578K	Buy	+12,942	New	+$562K	0.03%	376

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Driehaus Capital Management's BMY Position: Q2 2023 in Review

Driehaus Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,735 shares — an estimated $259K sold.

Driehaus Capital Management first reported a position in BMY in Q2 2013 and held it in 14 quarters. The position peaked at $7.82M in Q1 2014. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Driehaus Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Driehaus Capital Management sold 3,735 Bristol-Myers Squibb shares in Q2 2023, an estimated $259K.
Driehaus Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 14 quarters.
Driehaus Capital Management's Bristol-Myers Squibb position peaked at $7.82M in Q1 2014.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Driehaus Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.